WEKO3
アイテム
遷延する血小板減少および致死的転帰の予測因子としての循環シンデカン-1 : 集中治療を必要とする敗血症が疑われる患者を対象とした研究
http://hdl.handle.net/10232/00031990
http://hdl.handle.net/10232/00031990171b9015-c469-4f3e-bccd-c53183d576d1
名前 / ファイル | ライセンス | アクション |
---|---|---|
Diss_畠中_公作_ISK651_2021 (4.4 MB)
|
||
Abstract_畠中_公作_4518810315_2021 (69.0 kB)
|
|
|
Result_Hatanaka_Kosaku_isk_651 (4.4 MB)
|
|
|
Comments_Hatanaka_Kosaku_isk_651 (2.3 MB)
|
|
Item type | 学位論文 / Thesis or Dissertation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2022-05-27 | |||||
タイトル | ||||||
タイトル | Circulating syndecan-1 as a predictor of persistent thrombocytopenia and lethal outcome : a population study of patients with suspected sepsis requiring intensive care | |||||
言語 | en | |||||
タイトル | ||||||
タイトル | 遷延する血小板減少および致死的転帰の予測因子としての循環シンデカン-1 : 集中治療を必要とする敗血症が疑われる患者を対象とした研究 | |||||
言語 | ja | |||||
著者 |
畠中, 公作
× 畠中, 公作 |
|||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | sepsis | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | glycocalyx | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | syndecan 1 | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | thrombocytopenia | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | endotheliopathy | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_db06 | |||||
資源タイプ | doctoral thesis | |||||
アクセス権 | ||||||
アクセス権 | open access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||
要約(Abstract) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Background: Sepsis is defined as life-threatening organ dysfunction caused by dysregulated host responses to infection. Recent studies have suggested that endotheliopathy may be the common basis for multiple organ failure in sepsis. Under septic conditions, accumulation of proteases accelerates shedding of proteoglycans, such as syndecan-1, from the endothelial surface, resulting in augmented leukocyte adhesion to the vascular wall, enhanced vascular permeability, and intravascular coagulation. The purpose of this study was to determine the potential utility of syndecan-1 as a biomarker linking endotheliopathy to organ failure. Methods: One hundred patients with suspected infections who were admitted to the intensive care unit (ICU) at Kagoshima University Hospital were consecutively enrolled in the study. Serum syndecan-1 levels were measured using an in-house enzyme-linked immunosorbent assay. The difference between serum syndecan-1 levels in 28-day survivors and non-survivors was analyzed by the Mann–Whitney U-test. Receiver-operating characteristics curve analysis with area under the curve calculation was used to quantify the predictive performance of serum syndecan-1 for 28-day mortality. The correlations between serum syndecan-1 and coagulation markers were analyzed by Spearman's rank correlation test. Results: Serum syndecan-1 levels in non-survivors were significantly higher than those in survivors on Day 1 and Day 3 (P < 0.01). Among multiple organ failures, coagulation failure and renal failure were significantly correlated with serum syndecan-1. Spearman's rank correlation test indicated that serum syndecan-1 was weakly but significantly correlated with disseminated intravascular coagulation score (rho = 0.33, P < 0.01). Patients with serum syndecan-1 ≥21.4 ng/mL showed delayed recovery from thrombocytopenia relative to patients with serum syndecan-1 <21.4 ng/mL. Conclusions: Elevated circulating syndecan-1 on the first day of ICU admission was associated with persistent thrombocytopenia and lethal outcome in patients with suspected sepsis. Kosaku Hatanaka, Takashi Ito, Yutaro Madokoro, Chinatsu Kamikokuryo, Shuhei Niiyama, Shingo Yamada, Ikuro Maruyama and Yasuyuki Kakihana Circulating Syndecan-1 as a Predictor of Persistent Thrombocytopenia and Lethal Outcome: A Population Study of Patients With Suspected Sepsis Requiring Intensive Care Frontiers in Cardiovascular Medicine 8:730553 https://doi.org/10.3389/fcvm.2021.730553 |
|||||
言語 | en | |||||
作成日 | ||||||
日付 | 2022-03-04 | |||||
日付タイプ | Collected | |||||
出版タイプ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
NDC | ||||||
主題Scheme | NDC | |||||
主題 | 490 | |||||
ファイル(説明) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 博士論文全文, 博士論文要旨, 最終試験結果の要旨, 論文審査の要旨 | |||||
言語 | ja | |||||
公開者・出版者 | ||||||
出版者 | Frontiers | |||||
言語 | en | |||||
公開者・出版者 | ||||||
出版者 | 鹿児島大学 | |||||
言語 | ja | |||||
公開者・出版者 | ||||||
出版者 | カゴシマ ダイガク | |||||
言語 | ja-Kana | |||||
備考 | ||||||
値 | 【指導教員:垣花泰之】 | |||||
date.appl | ||||||
値 | 【学位申請日】2022-01-05 | |||||
学位名 | ||||||
言語 | ja | |||||
学位名 | 博士(医学) | |||||
学位名 | ||||||
言語 | en | |||||
学位名 | Doctor of Philosophy in Medical Science | |||||
学位授与機関 | ||||||
学位授与機関識別子Scheme | kakenhi | |||||
学位授与機関識別子 | 17701 | |||||
言語 | ja | |||||
学位授与機関名 | 鹿児島大学 | |||||
学位授与年月日 | ||||||
学位授与年月日 | 2022-03-25 | |||||
学位授与番号 | ||||||
学位授与番号 | 甲総研第651号 |